Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 1470 is a short, non-coding RNA molecule encoded in the human genome that regulates gene expression by binding to specific mRNA targets, leading to their translational repression or degradation. In esophageal squamous cell carcinoma, miR-1470 is notably overexpressed, promoting cancer cell proliferation, migration, and inhibiting cellular senescence by modulating the cell cycle regulator cyclin E1 and the expression of matrix metalloproteinases (MMP2, MMP13, MMP14). Suppression of miR-1470 can induce apoptosis via the Bcl-2 pathway and promote cell senescence. These findings highlight its function as an oncogenic miRNA and suggest that miR-1470 may be a promising therapeutic target and a diagnostic marker for ESCC. No small molecule drugs or biologics directly targeting miR-1470 are clinically available, but experimental miRNA inhibitors function by downregulating its expression or blocking its activity.
Mechanisms for drugs (inhibitors) targeting miR-1470 include: inhibition of miR-1470 to restore apoptosis; downregulation of cell cycle progression genes such as cyclin E1 (CCNE1); suppression of migration by inhibiting MMPs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 1470 (miR-1470).